Literature DB >> 3498574

Isolation and purification of ILS, an interleukin 1 inhibitor produced by human gingival epithelial cells.

L J Walsh1, P E Lander, G J Seymour, R N Powell.   

Abstract

Recent studies have described the presence of an interleukin 1 (IL-1) inhibitor (ILS) in supernatants from human gingival organ cultures. This report describes the isolation and purification of ILS. ILS was produced in serum-free medium and purified to apparent homogeneity by ion exchange chromatography and high pressure liquid chromatography. IL-1 and ILS eluted as discrete proteins using this system, with ILS appearing as a single protein band of 97,400 molecular weight on SDS-PAGE. ILS inhibited the effects of both murine IL-1 and IL-2 on thymocyte proliferation, and was heat resistant, moderately resistant to freeze-thawing and stable for 2 years at 0-4 degrees C or -20 degrees C. Production of ILS by gingival epithelial cell cultures was not affected by depletion of Langerhans cells, implying that ILS is primarily a keratinocyte product.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3498574      PMCID: PMC1542721     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  16 in total

1.  Characterization of lymphocyte-activating factor (LAF) produced by a macrophage cell line, P388D1. II. Biochemical characterization of LAF induced by activated T cells and LPS.

Authors:  S B Mizel; J J Oppenheim; D L Rosentreich
Journal:  J Immunol       Date:  1978-05       Impact factor: 5.422

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis.

Authors:  K Weber; M Osborn
Journal:  J Biol Chem       Date:  1969-08-25       Impact factor: 5.157

4.  Loss of Langerhans cells from gingival tissue maintained in organ culture.

Authors:  L J Walsh; R N Powell; G J Seymour; G M Newcomb
Journal:  J Oral Pathol       Date:  1984-12

5.  Optimized conditions for the growth of human epidermal cells in culture.

Authors:  P Hawley-Nelson; J E Sullivan; M Kung; H Hennings; S H Yuspa
Journal:  J Invest Dermatol       Date:  1980-08       Impact factor: 8.551

6.  Regulation of the production of immune interferon and cytotoxic T lymphocytes by interleukin 2.

Authors:  W L Farrar; H M Johnson; J J Farrar
Journal:  J Immunol       Date:  1981-03       Impact factor: 5.422

7.  Identification of a specific interleukin 1 inhibitor in the urine of febrile patients.

Authors:  Z Liao; R S Grimshaw; D L Rosenstreich
Journal:  J Exp Med       Date:  1984-01-01       Impact factor: 14.307

8.  Characterization of a human interleukin 1 inhibitor.

Authors:  Z Liao; A Haimovitz; Y Chen; J Chan; D L Rosenstreich
Journal:  J Immunol       Date:  1985-06       Impact factor: 5.422

9.  In vitro mixed skin cell lymphocyte culture reaction (MSLR) in man: analysis of the epidermal cell and T cell subpopulations.

Authors:  J Czernielewski; M Faure; D Schmitt; J Thivolet
Journal:  Clin Exp Immunol       Date:  1982-11       Impact factor: 4.330

10.  Accessory cell function of human B cells. I. Production of both interleukin 1-like activity and an interleukin 1 inhibitory factor by an EBV-transformed human B cell line.

Authors:  G Scala; Y D Kuang; R E Hall; A V Muchmore; J J Oppenheim
Journal:  J Exp Med       Date:  1984-06-01       Impact factor: 14.307

View more
  5 in total

1.  Glucocorticoid-induced keratinocyte-derived interleukin-1 receptor antagonist(s).

Authors:  S Stosić-Grujicić; M L Lukić
Journal:  Immunology       Date:  1992-02       Impact factor: 7.397

2.  A novel urinary sialoglycoprotein as the inhibitor of interleukin-1.

Authors:  S Kabir; H Wigzell
Journal:  Clin Exp Immunol       Date:  1989-07       Impact factor: 4.330

3.  Release of interleukin 1 inhibitory activity (contra-IL-1) by human monocyte-derived macrophages infected with human immunodeficiency virus in vitro and in vivo.

Authors:  R M Locksley; S Crowe; M D Sadick; F P Heinzel; K D Gardner; M S McGrath; J Mills
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

4.  Production of an interleukin-1 inhibitor by cell line P388D1 murine macrophages stimulated with Haemophilus actinomycetemcomitans lipopolysaccharide.

Authors:  T Nishihara; T Koga; S Hamada
Journal:  Infect Immun       Date:  1988-11       Impact factor: 3.441

5.  An interleukin-1 inhibitor in gingival crevicular fluid of patients with chronic inflammatory periodontal disease.

Authors:  H Kabashima; K Maeda; H Iribe; K Yamashita; T Hirofuji; Y Iwamoto; M Aono
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.